Stocks · Health care · Pharmaceutical Preparations

Emergent BioSolutions Inc.

EBS Clue Score47
United States Fiscal year ends December CIK 0001367644 Results filed 2 Nov 2026

What the insiders did Net selling

By person

17 insiders · 15 transactions
3.3×

Joseph Papa holds only 3.3 times base salary in stock. $3.50M of shares against $1.04M in salary for 2025.

Salary from the company's own proxy. The shares are what Joseph Papa last reported holding, valued at $7.09, the price Common Stock was last bought or sold at on the open market here, on 7 Oct 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Donald W DeGolyer
Director
—
$443.82K (4) scheduled
−$443.82K
111,921
0.2183%
$793.52K
−17.8%
Ronald Richard
Director
—
$263.08K (2) scheduled
−$263.08K
123,761
0.2414%
$877.47K
+74.0%
Sujata Tyagi Dayal
Director
—
$201.13K (3) scheduled
−$201.13K
100,563
0.1961%
$712.99K
+59.3%
Kathryn C Zoon
Director
—
$144.45K (2) scheduled
−$144.45K
79,941
0.1559%
$566.78K
+46.7%
Keith Katkin
Director
—
$128.18K (1) scheduled
−$128.18K
96,294
0.1878%
$682.72K
+60.8%
Paul Anthony Williams
SVP, Products Business
—
$78.55K (3) scheduled
−$78.55K
156,098
0.3044%
$1.11M
+541.5%
Joseph C Papa
President and CEO
—
—
—
493,153
0.9618%
$3.50M
—
Richard S Lindahl
EVP, Chief Financial Officer
—
—
—
374,083
0.7296%
$2.65M
+118.8%
Coleen Glessner
EVP, Quality & Ethics, and CPL
—
—
—
202,201
0.3944%
$1.43M
+23.9%
William Hartzel
SVP, Bioservices
—
—
—
185,558
0.3619%
$1.32M
+285.7%
Simon C Lowry
SVP, R&D, CMO
—
—
—
177,914
0.3470%
$1.26M
—
Jessica Perl
SVP, General Counsel, Corp Sec
—
—
—
165,286
0.3224%
$1.17M
+2,329%
Neal Franklin Fowler
Director
—
—
—
160,847
0.3137%
$1.14M
+18.2%
Zsolt Harsanyi
Chairman
—
—
—
149,076
0.2907%
$1.06M
+66.9%
Louis W Sullivan
Director
—
—
—
139,098
0.2713%
$986.20K
+32.9%
Marvin L White
Director
—
—
—
113,839
0.2220%
$807.12K
+66.5%
John D Fowler Jr
Director
—
—
—
30,350
0.0592%
$215.18K
—